Latest filing published 03 Feb 2026 for Rhythm Pharmaceuticals, INC..
Pamela J. Cramer is a declared insider of Rhythm Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 63 filings, for trades running from 26 July 2022 to 1 February 2026.
No open-market purchase appears, only 33 sales worth €9.8M. The rest of the record consists of 2 share grants and 28 option exercises.
The newest entry dates from 3 February 2026: a share grant of €431k, in Rhythm Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations